REQUEST A DEMO
Total
USD $0.00
Search more companies

Premed Pharma Plus Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Premed Pharma Plus Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Premed Pharma Plus Company Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. It operates in the Pharmacies and Drug Stores industry. It was first established on July 06, 2026. Premed Pharma Plus Company Limited currently employs 18 (estimated) people. From the latest financial highlights, Premed Pharma Plus Company Limited reported a net sales revenue increase of 13.85% in 2025. Its’ total assets recorded a growth of 28.67%. The net profit margin of Premed Pharma Plus Company Limited decreased by 2.65% in 2025.

Headquarters
17 Soi Onnuch64
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10250

Contact Details: Purchase the Premed Pharma Plus Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Premed Pharma Plus Company Limited report to view the information.
Financial Auditors:
Purchase the Premed Pharma Plus Company Limited report to view the information.
Incorporation Date:
July 06, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Premed Pharma Plus Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
13.85%
Total Operating Revenue
13.83%
Operating Profit
-30.88%
Net Profit/Loss for the Period
-90.52%
Total Assets
28.67%
Total Equity
2.14%
Operating Profit Margin
-2.74%
Net Profit Margin
-2.65%
Return on Equity (ROE)
-20.46%
Debt / Equity
70.1%
Quick Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?